Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-06-17
1999-07-20
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514290, 544361, 546 93, C07D40104, C07D40112, A61K 3144, A61K 31495
Patent
active
059256397
ABSTRACT:
Compounds of the following formula useful for inhibiting Ras function and therefore inhibiting or treating the abnormal growth of cells are disclosed: ##STR1## or an N-oxide thereof, or a pharmaceutically acceptable salt or solvate thereof, wherein:
REFERENCES:
patent: 5151423 (1992-09-01), Piwinski et al.
patent: 5684013 (1997-11-01), Afonso et al.
patent: 5696121 (1997-12-01), Bishop et al.
patent: 5714609 (1998-02-01), Doll et al.
patent: 5719148 (1998-02-01), Bishop et al.
Njoroge et al, Bioorganic & Med. Chem. Let., 6 (1996), pp. 2977-2982.
Njoroge et al, Bioorganic & Med. Chem. Let., 5 (1997), pp. 101-113.
Buss et al, Chem. and Bio., 118 (1995), pp. 787-791.
Bishop et al, J. Biol. Chem., 270 (1995), pp. 30611-30618.
Alvarez Carmen
Doll Ronald J.
Lalwani Tarik
Magatti Anita W.
Rotman Alan L.
Schering Corporation
LandOfFree
Keto amide derivatives useful as farnesyl protein transferase in does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Keto amide derivatives useful as farnesyl protein transferase in, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Keto amide derivatives useful as farnesyl protein transferase in will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1322050